New and Generic Drug Approvals:

*Alendronate Sodium Tablets, Sun Pharmaceutical Industries, Ltd., Approval *DETROL (tolterodine tartrate) Tablets, Pfizer Global Pharmaceuticals, Labeling Revision *DETROL LA (tolterodine tartrate) Extended-Release Capsules, Pfizer Global Pharmaceuticals, Labeling Revision *Galantamine Hydrobromide Tablets, Dr. Reddy's Laboratories, Ltd., Approval *NEOPROFEN (ibuprofen lysine) Intravenous Injection, Ovation Pharmaceuticals, Inc., Labeling Revision *Potassium Chloride 0.149% in Sodium Chloride 0.45% in Plastic Container (potassium chloride and sodium chloride) Injection, Hospira Inc., Approval *REMODULIN (treprostinil sodium) Subcutaneous I.V. Injection, United Therapeutics Corp., Labeling Revision *STROMECTOL (ivermectin) Tablets, Merck & Co., Inc., Labeling Revision 

Source: FDA


Zynchros Pharmacy Services